In the validation of pathways, key targets (INSR, PTPN1, PPARA, and PPARG) from two of the most significant pathways in pathway enrichment analysis, Insulin resistance, and PPAR signaling pathway, were selected. The gene discussed is PTPN1; the disease is Insulin resistance.